GW’s Cannabis-Based Epilepsy Drug Set For European Approval
Cannabis Law Report
JULY 30, 2019
Last year, the drug became the first cannabis-based medicine to be approved in the United States after regulators permitted the treatment for two other forms of childhood epilepsy and the US Drug Enforcement Administration labelled the drug as having a low abuse potential.
Let's personalize your content